Safety and Tolerability of BRAF Inhibitor and BRAF Inhibitor-Based Combination Therapy in Chinese Patients With Advanced Melanoma: A Real World Study

The toxicity spectrum between Chinese and Caucasian patients with melanoma who were treated with BRAF inhibitors (BRAFi) may differ. The purpose of the present study was to assess the safety and tolerability of BRAFi and BRAFi-based combination therapies [MEK inhibitors (MEKi) or anti-programmed dea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Liu, Xing, Li, Jing-jing, Ding, Ya, Li, Dan-dan, Wen, Xi-zhi, Weng, De-sheng, Wang, Jiu-hong, Jiang, Hang, Zhang, Xiao-shi
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8047100/
https://ncbi.nlm.nih.gov/pubmed/33868987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.582676
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados